Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Among the dietary factors, early introduction of cow milk and the level of 25(OH)D were analyzed, and the analysis did not show significant differences between the groups.
Source: Risk factor analysis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In the cross-sectional part of the study, 277 patients aged 1 to 17 years with new-onset T1D hospitalized in Children’s Clinical University Hospital between 2017 and 2024 were selected and divided into two groups depending on COVID-19 history prior to T1D onset: (1) research group (past, laboratory-proven infection or positive SARS-CoV-2 antibodies at the time of hospitalization); (2) control group (negative COVID-19 history and prepandemic patients).
Source: Abstract.
This was a cross-sectional study where patients 1 to 17 years of age with new-onset T1D were included retrospectively from 2017 and prospectively from August 2022 to January 2024.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic
Cross-sectional study · Frontiers in Pediatrics · 2026
Original publication title
Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic
© 2026 Braivo, Truškova, Lavrenova, Ķīvīte-Urtāne, Pavāre and Dzīvīte-Krišāne.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
During the COVID-19 pandemic in Latvia, there was a significant increase in new-onset childhood type 1 diabetes (T1D). The aim of this study is to analyze the influence of SARS-CoV-2 virus on initial manifestation of T1D and patterns of risk factors for disease development in children.
Source: BackgroundAbstract: What methods does the paper describe?
In the cross-sectional part of the study, 277 patients aged 1 to 17 years with new-onset T1D hospitalized in Children’s Clinical University Hospital between 2017 and 2024 were selected and divided into two groups depending on COVID-19 history prior to T1D onset: (1) research group (past, laboratory-proven infection or positive SARS-CoV-2 antibodies at the time of hospitalization); (2) control group (negative COVID-19 history and prepandemic patients). Initial manifestation was evaluated by analyzing clinical presentation and blood gas tests. Among the risk factors, prenatal, dietary, and hereditary factors and infections were analyzed.
Source: Materials and methodsAbstract: Results
The rate of incidence of T1D increased by 37.6% during the COVID-19 pandemic in Latvia (p < 0.001). Children from the research group had a significantly more severe initial manifestation with lower pH levels at the time of admission (p = 0.04). No association between more severe clinical presentation and delayed arrival at the hospital for any reason was found. There was a significantly lower prevalence of T1D in the family members of those patients exposed to SARS-CoV-2.
Source: ResultsAbstract: Conclusion
After exposure to SARS-CoV-2, patients in the cohort group had a more severe initial manifestation of T1D than patients without a history of COVID-19, which could not be attributed to the restrictions imposed by the pandemic or to other changes resulting from patient or primary care decisions.
Source: ConclusionAuthors’ abstract
Background
During the COVID-19 pandemic in Latvia, there was a significant increase in new-onset childhood type 1 diabetes (T1D). The aim of this study is to analyze the influence of SARS-CoV-2 virus on initial manifestation of T1D and patterns of risk factors for disease development in children.
Materials and methods
In the cross-sectional part of the study, 277 patients aged 1 to 17 years with new-onset T1D hospitalized in Children’s Clinical University Hospital between 2017 and 2024 were selected and divided into two groups depending on COVID-19 history prior to T1D onset: (1) research group (past, laboratory-proven infection or positive SARS-CoV-2 antibodies at the time of hospitalization); (2) control group (negative COVID-19 history and prepandemic patients). Initial manifestation was evaluated by analyzing clinical presentation and blood gas tests. Among the risk factors, prenatal, dietary, and hereditary factors and infections were analyzed.
Results
The rate of incidence of T1D increased by 37.6% during the COVID-19 pandemic in Latvia (p < 0.001). Children from the research group had a significantly more severe initial manifestation with lower pH levels at the time of admission (p = 0.04). No association between more severe clinical presentation and delayed arrival at the hospital for any reason was found. There was a significantly lower prevalence of T1D in the family members of those patients exposed to SARS-CoV-2.
Conclusion
After exposure to SARS-CoV-2, patients in the cohort group had a more severe initial manifestation of T1D than patients without a history of COVID-19, which could not be attributed to the restrictions imposed by the pandemic or to other changes resulting from patient or primary care decisions.
Publication and source details
Original title: Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic
Lizete Braivo; Viktorija Truškova; Aļona Lavrenova; Anda Ķīvīte-Urtāne; Jana Pavāre; Iveta Dzīvīte-Krišāne
Frontiers in Pediatrics · 2026
* Correspondence: Lizete Braivo lizete.braivo@bkus.lv© 2026 Braivo, Truškova, Lavrenova, Ķīvīte-Urtāne, Pavāre and Dzīvīte-Krišāne.2026Braivo, Truškova, Lavrenova, Ķīvīte-Urtāne, Pavāre and Dzīvīte-Krišānehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:28:07.774818+00:00
DOI: 10.3389/fped.2026.1804669 · PMC13236654